Utah’s Life Sciences Companies
-
ARUP Announces Partnership with TellBio for Use of TellBio’s Novel Circulating Tumor Cells Technology
ARUP Laboratories on May 10 announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use…
-
Xenter Closes Series A at $12M; Adds Four Additional Board Members
Xenter has announced the appointment of four additional industry leaders to its Board of Directors and the closing…
-
IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO
IDbyDNA, the pioneer in precision metagenomics, has appointed Next-Generation Sequencing (NGS) leader Neil Gunn as its new CEO…
-
SINTX Technologies Files Multiple New U.S. and International Patent Applications
This week SINTX Technoloiges announced multiple U.S. and international patent applications for development of new technologies utilizing the…
-
Foldax Named Among Fierce Medtech’s “Fierce 15” Companies of 2020
Foldax was named by Fierce Medtech as one of the 2020 “Fierce 15,” designating it as one of the…
-
U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone
DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function…
-
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India
Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd)…
-
Canary Speech and Constant Companion Partner to Help Diagnose Behavioral Health Issues
Utah Business Magazine has highlighted a new partnership between Constant Companion and Canary Speech to study how voice technology…
-
UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES
The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership…
-
PhotoPharmics Innovations Address Global Health Inequalities
PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’…
-
SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from…
-
Innovative Med Tech Startup Xenter Announces Company Launch
Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur…
-
Utah’s Recursion Goes Public – Announces Pricing of IPO
Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock…
-
IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee
IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee.…
-
FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process
On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test…
-
Utah’s Biomerics Announces Expansion of Texas, Costa Rica Operations
Biomerics, headquartered in Salt Lake City, and a leading mid-market medical device contract manufacturer, has announced it is…
-
IONIQ Sciences Finalist in National ‘Buzz of BIO’ Awards
Utah’s own IONIQ Sciences was named a finalist for the prestigious ‘Buzz of BIO 2021’ award in the…
-
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®
Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses…
-
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce…
-
American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health
RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11.…
-
Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies
Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh…
-
Novel Embolic Device Used for Arterial and Venous Tumor Treatments
Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block…
-
MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE
Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address –…
-
Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer
Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of…
-
Control Medical Technology Announces New Device Removes Large Blood Clots in 1st Deep Vein Thrombosis (DVT) Patient Use
Control Medical Technology today announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large…
-
SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in…
-
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products
Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly…
-
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited; Provides Corporate Update
Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”)…
-
Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita
Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression…
-
Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ Platform
Co-Diagnostics has announced that it has completed principal design work for a PCR test that would allow researchers…
-
Vertex Announces FDA Approvals for Expanded Use of Cystic Fibrosis Medicines
Vertex has announced FDA approval of eligibility for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include people with cystic fibrosis (CF)…
-
Phoenix PharmaLabs Announces New Investment Offering with Netcapital
Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced…
-
Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test
Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers…
-
ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark
ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The…
-
Braveheart Brings Healthcare to India’s Last Mile Community
These days we can all use uplifting news, so please check out this short story about how BraveHeart…
-
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing…
-
Milken Institute Ranks Utah Sixth in Nation for Innovation Capacity
The Milken Institute 2020 State Technology and Science Index ranks Utah #6 in the nation for its knowledge…
-
Utah Life Sciences Leaders Honored At 2020 Virtual Life Sciences Summit
On the last day of the Summit, BioUtah announced its 2020 Utah Life Sciences award winners, which were presented during…
-
Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance
Quansys Biosciences has received emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
